Hallgeir Rui

Cited by

	All	Since 2017
Citations	9923	2871
h-index	59	30
i10-index	139	78

600

300

150

450

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202239 39 100 154 185 174 223 198 226 165 182 267 208 236 216 290 316 273 411 432 466 517 484 532 523 447 424 475 530 591 401

Public access

View all

70 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Richard PestellDirector of Kimmel Cancer Center and Executive VP, Thomas Jefferson UniversityVerified email at jefferson.edu
T HyslopProfessor, Duke UniversityVerified email at duke.edu
Michael P. Lisanti, MD-PhD, FRSA, FR...Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)Verified email at salford.ac.uk
Kay-Uwe WagnerProfessor, Karmanos Cancer Institute, Wayne State UniversityVerified email at wayne.edu
Inna ChervonevaProfessor of Biostatistics, Thomas Jefferson UniversityVerified email at jefferson.edu
Chenguang WangLIPOGEN LLC.Verified email at lipogenes.com
Federica Sotgia, PhDProfessor & Chair, University of Salford (Greater Manchester), UKVerified email at salford.ac.uk
Hai HuChief Scientific Officer, Chan Soon-Shiong Institute of Molecular Medicine at WindberVerified email at wriwindber.org
Xuanmao JiaoPh.D., Associate Professor, Baruch S. Blumberg InstituteVerified email at bblumberg.org
David RimmYale UniversityVerified email at yale.edu
Lawrence Andrew ShirleyAssistant Professor of Surgery, The Ohio State UniversityVerified email at osu.edu
Lothar HennighausenScientist and RandonneurVerified email at mail.nih.gov
Peter McCueDirector of Pathology, Jefferson UniversityVerified email at jefferson.edu
Magliocco AnthonyH Lee Moffitt Cancer CenterVerified email at moffitt.org
Lukas BubendorfProfessor, Institute of Pathology, University Hospital BaselVerified email at usb.ch
Isabelle MercierUniversity of the Sciences in PhiladelphiaVerified email at usciences.edu
Gloria Bonuccelli, PhDUniversity of SalfordVerified email at salford.ac.uk
Daniel BeitingAssistant Professor, University of PennsylvaniaVerified email at vet.upenn.edu
Constantinos KoumenisDepartment of Radiation Oncology, University of Pennsylvania School of MedicineVerified email at upenn.edu
Jan Oxholm GordeladzeProfessor, PhD, Institute of Basic Medical Science, Department of Biochemistry, University of Oslo, NorwayVerified email at medisin.uio.no

Hallgeir Rui

Professor of Pathology, Medical College of Wisconsin

Verified email at mcw.edu - Homepage

Breast Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Activation of receptor-associated tyrosine kinase JAK2 by prolactin. H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (7), 5364-5368, 1994	406	1994
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast CancerMiR-195 and MiR-497 in Breast Cancer D Li, Y Zhao, C Liu, X Chen, Y Qi, Y Jiang, C Zou, X Zhang, S Liu, X Wang, ... Clinical cancer research 17 (7), 1722-1730, 2011	333	2011
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation PM Grimley, F Dong, H Rui Cytokine & growth factor reviews 10 (2), 131-157, 1999	271	1999
Signal transducer and activator of transcription-5 activation and breast cancer prognosis MT Nevalainen, J Xie, J Torhorst, L Bubendorf, P Haas, J Kononen, ... Journal of Clinical Oncology 22 (11), 2053-2060, 2004	256	2004
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells AS Sultan, J Xie, MJ LeBaron, EL Ealley, MT Nevalainen, H Rui Oncogene 24 (5), 746-760, 2005	223	2005
Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 L DaSilva, H Rui, RA Erwin, OMZ Howard, RA Kirken, MG Malabarba, ... Molecular and cellular endocrinology 117 (2), 131-140, 1996	205	1996
Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors L DaSilva, OM Howard, H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (28), 18267-18270, 1994	185	1994
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells H Yamashita, J Xu, RA Erwin, WL Farrar, RA Kirken, H Rui Journal of Biological Chemistry 273 (46), 30218-30224, 1998	184	1998
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response A Ertel, JL Dean, H Rui, C Liu, A Witkiewicz, KE Knudsen, ES Knudsen Cell cycle 9 (20), 4153-4163, 2010	182	2010
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice KU Wagner, A Krempler, AA Triplett, Y Qi, NM George, J Zhu, H Rui Molecular and cellular biology 24 (12), 5510-5520, 2004	177	2004
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells TJ Ahonen, J Xie, MJ LeBaron, J Zhu, M Nurmi, K Alanen, H Rui, ... Journal of Biological Chemistry 278 (29), 27287-27292, 2003	170	2003
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization H Rui, JJ Lebrun, RA Kirken, PA Kelly, WL Farrar Endocrinology 135 (4), 1299-1306, 1994	167	1994
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression KU Wagner, H Rui Journal of mammary gland biology and neoplasia 13 (1), 93-103, 2008	164	2008
Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment KV Katlinski, J Gui, YV Katlinskaya, A Ortiz, R Chakraborty, ... Cancer cell 31 (2), 194-207, 2017	163	2017
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. H Rui, JY Djeu, GA Evans, PA Kelly, WL Farrar Journal of Biological Chemistry 267 (33), 24076-24081, 1992	161	1992
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer AK Witkiewicz, A Dasgupta, K Nguyen, C Liu, AJ Kovatich, GF Schwartz, ... Cancer biology & therapy 8 (11), 1071-1079, 2009	143	2009
Effects of growth hormone and prolactin immune development and function WJ Murphy, H Rui, DL Longo Life sciences 57 (1), 1-14, 1995	143	1995
Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless RA Erwin, RA Kirken, MG Malabarba, WL Farrar, H Rui Endocrinology 136 (8), 3512-3518, 1995	134	1995
Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. JY Djeu, JH Liu, S Wei, H Rui, CA Pearson, WJ Leonard, DK Blanchard The Journal of Immunology 150 (3), 960-970, 1993	121	1993
Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor β-chain RA Kirken, H Rui, GM Malabarba, ZOM Howard, M Kawamura, JJ O'Shea, ... Cytokine 7 (7), 689-700, 1995	117	1995

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors